NLRP3 and peritonitis: Dopamine-mediated DRD1 signaling also prevents both LPS-induced systemic inflammation and MSU-induced peritonitis through suppression of IL-1β production via inhibition of NLRP3 inflammasome activation, but not by suppression of TNF-α (44).